Streetbeat News

Partnerships

LQDA

Liquidia Corporation (NASDAQ:LQDA) has secured $100M in new financings, comprising a $75M private placement of common stock to a Patient Square Capital fund and a $25M advance from HealthCare Royalty. The stock sale is at an 8% discount to the prior closing price, and the advance is part of an existing agreement. These funds will support Liquidia's objectives for 2024, potentially leading to profitability with the launch of YUTREPIA for PAH and PH-ILD treatment. Liquidia has raised a total of $126M in recent financings.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:15 pm

AAPL

Apple Fitness+ is expanding its offerings with new features starting January 8, including a sound meditation theme, a workout program with golfer Rose Zhang, an Artist Spotlight series with music from USHER and other artists, and Time to Walk episodes on Apple Podcasts. The service is also accessible through Anytime Fitness memberships, and Apple is offering a limited-edition award for closing Activity rings. Fitness+ is available as a standalone subscription or part of the Apple One Premier plan, with various pricing options and included in certain Apple product purchases.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:06 pm

INDI

Ficosa and indie Semiconductor have entered into a joint global commercialization agreement to develop and commercialize automotive camera solutions with neural network-based AI processing. These solutions aim to provide best-in-class imaging and detection to meet the latest automotive safety regulations. The partnership expects to begin sampling its first smart camera solutions in 2024, with full-scale production anticipated by 2025.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:04 pm

PTON

Peloton Interactive Inc. (NASDAQ:PTON) has announced a partnership with TikTok to launch a new fitness hub, “#TikTokFitness Powered by Peloton,” featuring fitness videos and live classes. This move is part of Peloton's strategy to reach a broader customer base and reshape its brand identity, targeting a younger audience and aiming to boost app downloads and conversions. The collaboration follows Peloton's rebranding efforts and tiered pricing strategy for its app, amidst declining sales, profits, and membership.

Portfolio Pulse from Benzinga Neuro

January 04, 2024 | 2:01 pm

QCOM

Qualcomm Technologies, a subsidiary of Qualcomm Inc (NASDAQ:QCOM), has announced the Snapdragon XR2+ Gen 2 Platform, which offers enhanced visual fidelity for AR and VR experiences. The new platform boasts a 15% higher GPU frequency and a 20% higher CPU frequency compared to its predecessor, supporting 4.3K spatial computing at 90 fps. It can handle 12 or more concurrent cameras for advanced tracking capabilities. Qualcomm collaborates with Samsung and Google to deliver top-tier XR experiences for Galaxy users. QCOM's stock saw a slight decrease of 1.01% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

January 04, 2024 | 2:00 pm

FUBO

FuboTV Inc (NYSE:FUBO) shares are trading higher after announcing a multi-year distribution agreement with Nexstar Media, covering 89 local TV stations. This follows a recent debt reduction move by FuboTV, where it closed a privately negotiated exchange to reduce its debt by $28.3 million. The company's stock price has risen 2.76% to $2.98.

Portfolio Pulse from Adam Eckert

January 04, 2024 | 1:59 pm

SILO

Silo Pharma has announced its intention to submit a pre-IND (Investigational New Drug) application to the FDA in the first quarter of 2024. This decision is based on preclinical data and collaborative efforts with Columbia University. The submission will mark a significant milestone for the company as it progresses towards potential clinical trials for its drug candidates.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:55 pm

ABBV

AbbVie has entered into a strategic collaboration with Umoja Biopharma to develop novel in-situ CAR-T cell therapies for oncology. The partnership will combine Umoja's VivoVecTM gene delivery platform with AbbVie's oncology expertise to create CAR-T cell therapy candidates that are generated within the body.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:46 pm

OMGA

PTON

RPID

Omega Therapeutics (OMGA) stock surged 132% after announcing collaborations with Novo Nordisk for obesity and metabolic dysfunction-associated steatohepatitis treatments, with potential earnings up to $532M. Rapid Micro Biosystems (RPID) rose 55% as Samsung Biologics chose its Growth Direct platform for microbial quality control automation. Peloton (PTON) gained 10% on news of a partnership with TikTok for 'TikTokFitness Powered by Peloton', featuring live classes, original series, and celebrity collaborations.

Portfolio Pulse from ryanfaloona@benzinga.com

January 04, 2024 | 1:40 pm

SGN

Signing Day Sports, Inc. (NYSE:SGN) CEO Daniel Nelson provided a letter to stockholders highlighting the company's achievements in 2023 and its positive outlook for 2024. The company's IPO on the NYSE American exchange raised $6.0 million in gross proceeds. The funds will be used to grow the Signing Day Sports app, which aids high school athletes in the recruitment process. The company plans to increase direct digital marketing and leverage NIL opportunities for student-athletes. A collaboration with the U.S. Army Bowl showcased the app's capabilities. The appointment of Kevin Grogan as Senior Soccer Advisor and a partnership with EDP Soccer are expected to enhance the company's position in soccer recruitment. New AI initiatives are also being implemented to improve customer acquisition and the recruitment process.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:39 pm